Journal article
Clinical progress note: Phenobarbital in the treatment of alcohol withdrawal syndrome
Journal of hospital medicine, Vol.20(10), pp.1094-1098
10/2025
DOI: 10.1002/jhm.70088
PMID: 40443022
Abstract
Alcohol withdrawal syndrome (AWS) is a common condition experienced by hospitalized patients. Practice patterns have evolved over time to include the use of phenobarbital, a barbiturate, as an adjunct to benzodiazepines or as an alternative monotherapy. The American Society of Addiction Medicine (ASAM) has recommended the use of phenobarbital in the management of AWS in certain clinical contexts. The current evidence base for the use of phenobarbital in AWS remains limited, though sufficient to demonstrate safety and efficacy as an alternative to benzodiazepines.
Details
- Title: Subtitle
- Clinical progress note: Phenobarbital in the treatment of alcohol withdrawal syndrome
- Creators
- Thad E Abrams - Iowa City VA Health Care SystemMatthew V Ronan - Harvard University
- Resource Type
- Journal article
- Publication Details
- Journal of hospital medicine, Vol.20(10), pp.1094-1098
- DOI
- 10.1002/jhm.70088
- PMID
- 40443022
- NLM abbreviation
- J Hosp Med
- ISSN
- 1553-5606
- eISSN
- 1553-5606
- Publisher
- WILEY
- Language
- English
- Electronic publication date
- 05/29/2025
- Date published
- 10/2025
- Academic Unit
- Psychiatry; General Internal Medicine; Internal Medicine
- Record Identifier
- 9984825524202771
Metrics
3 Record Views